139 related articles for article (PubMed ID: 1116100)
21. The therapeutic implications of splenic involvement in stage IIIA Hodgkin's disease.
Levi JA; Wiernik PH
Cancer; 1977 May; 39(5):2158-65. PubMed ID: 404027
[TBL] [Abstract][Full Text] [Related]
22. Bulky mediastinal Hodgkin's disease: results of a combined modality approach (ABVD/MOPP alternating chemotherapy plus radiation therapy).
De Lena M; Ditonno P; Lorusso V; Timurian A; Pellecchia A; Brandi M; Berardi F; Marzullo F
Haematologica; 1993; 78(4):230-5. PubMed ID: 7507457
[TBL] [Abstract][Full Text] [Related]
23. [Second tumor following Hodgkin's disease].
Schmitt K; Tulzer W
Padiatr Padol; 1984; 19(3):259-62. PubMed ID: 6548008
[TBL] [Abstract][Full Text] [Related]
24. Radiation as salvage therapy for patients with Hodgkin's disease relapsing after MOPP (mechlorethamine, vincristine, prednisone, and procarbazine) chemotherapy.
Diehl LF; Perry DJ; Terebelo H; Baldwin PE; Hurwitz M; Kimball DB; Dorn RV
Cancer Treat Rep; 1983 Sep; 67(9):827-9. PubMed ID: 6883360
[TBL] [Abstract][Full Text] [Related]
25. [Results of combined chemotherapy (MOPP) in the treatment of patients with generalized Hodgkin's disease].
Aghai E; Kende G; Many A; Ramot B
Harefuah; 1974 Apr; 86(7):348-51. PubMed ID: 4846045
[No Abstract] [Full Text] [Related]
26. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
Liebman HA; Hum GJ; Sheehan WW; Ryden VM; Bateman JR
Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771
[TBL] [Abstract][Full Text] [Related]
27. [Treatment of Hodgkin's disease. Experience of the Hôpital Saint-Louis].
Boiron M; Teillet F; Weisgerber C; Dana M; Jacquillat C; Bernard J
Rev Prat; 1974 Oct; 24(45):3971-8. PubMed ID: 4445767
[No Abstract] [Full Text] [Related]
28. A randomized study in stage IIIB and IV Hodgkin's disease comparing eight courses of MOPP versus an alteration of MOPP with ABVD: a European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie controlled clinical trial.
Somers R; Carde P; Henry-Amar M; Tarayre M; Thomas J; Hagenbeek A; Monconduit M; de Pauw BE; Breed WP; Verdonck L
J Clin Oncol; 1994 Feb; 12(2):279-87. PubMed ID: 7509381
[TBL] [Abstract][Full Text] [Related]
29. The intergroup Hodgkin's disease in children. A study of stages I and II.
Gehan EA; Sullivan MP; Fuller LM; Johnston J; Kennedy P; Fryer C; Gilchrist GS; Hays DM; Hanson W; Heller R
Cancer; 1990 Mar; 65(6):1429-37. PubMed ID: 2407336
[TBL] [Abstract][Full Text] [Related]
30. Hodgkin disease clinical stages I, II, and III (A, B): results of radiotherapy with or without chemotherapy.
Patricio MB; Ricardo JA; Vilhena M; Branco F; De Ponte MA; Cabral R; Neves M; De Sousa JV
J Surg Oncol; 1983 Nov; 24(3):236-41. PubMed ID: 6688845
[TBL] [Abstract][Full Text] [Related]
31. Combined modality therapy of Hodgkin's disease: a report on the Stanford Trials.
Rosenberg SA; Kaplan HS; Portlock CS; Glatstein EJ
Cancer; 1978 Aug; 42(2 Suppl):991-1000. PubMed ID: 99226
[TBL] [Abstract][Full Text] [Related]
32. Alternating versus hybrid MOPP and ABVD combinations in advanced Hodgkin's disease: ten-year results.
Viviani S; Bonadonna G; Santoro A; Bonfante V; Zanini M; Devizzi L; Soncini F; Valagussa P
J Clin Oncol; 1996 May; 14(5):1421-30. PubMed ID: 8622055
[TBL] [Abstract][Full Text] [Related]
33. Combination chemotherapy of Hodgkin's disease.
Nison DW; Aisenberg AC
Cancer; 1974 Jun; 33(6):1499-504. PubMed ID: 4834147
[No Abstract] [Full Text] [Related]
34. Status and perspectives in chemotherapy of Hodgkin's disease.
Frei E
Arch Intern Med; 1973 Mar; 131(3):439-45. PubMed ID: 4739436
[No Abstract] [Full Text] [Related]
35. An evaluation of long-term survival and treatment complications in children with Hodgkin's disease.
Mauch PM; Weinstein H; Botnick L; Belli J; Cassady JR
Cancer; 1983 Mar; 51(5):925-32. PubMed ID: 6687379
[TBL] [Abstract][Full Text] [Related]
36. [Comments about use of polychemotherapy MOPP associated with radiotherapy in the treatment of early stages of Hodgkin's disease. Preliminary report of 58 patients (author's transl)].
Brun B; Alaoui Y; Kuentz M; Baillet F; Maylin C; Vernant JP; Reyes F; Rochant H; Pierquin B; Dreyfus B
Ann Med Interne (Paris); 1980; 131(4):239-43. PubMed ID: 7425449
[TBL] [Abstract][Full Text] [Related]
37. Combined chemotherapy (MOPP or ABVD)-radiotherapy approach in advanced Hodgkin's disease.
Bonadonna G; Zucali R; De Lena M; Valagussa P
Cancer Treat Rep; 1977 Aug; 61(5):769-77. PubMed ID: 70270
[No Abstract] [Full Text] [Related]
38. A Southwest Oncology Group: chemotherapy versus chemotherapy plus radiotherapy in treatment of stage III Hodgkin's disease.
Grozea PN; De Persio EJ; Coltman CA; Fabian CJ; Morrison FS; Gehan EA; Jones SE
Recent Results Cancer Res; 1982; 80():83-91. PubMed ID: 6173904
[TBL] [Abstract][Full Text] [Related]
39. Treatment of early stage Hodgkin's disease with radiation therapy plus short-cycle (3 MOPP) adjuvant chemotherapy.
Chisesi T; Ricciardi O; Dal Fior S; Cappellari F; Pozza F; Dini E
Tumori; 1983 Oct; 69(5):455-61. PubMed ID: 6689093
[TBL] [Abstract][Full Text] [Related]
40. Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: A 24-year follow-up study.
Salloum E; Doria R; Farber LR; Roberts KB; Cooper DL
Cancer J Sci Am; 1995; 1(4):267-73. PubMed ID: 9166487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
